Fact CheckerSign in

NCT06268808Completed

Initiation of Continuous Glucose Monitoring in Adults With Type 2 Diabetes Treated With Basal Insulin, in Italy

Source: ClinicalTrials.gov · Last updated 23 Dec 2025

Brief summary (registry, in English)

The goal of this clinical study is to determine the impact of starting the use of the FreeStyle Libre 2 glucose monitoring system, over a three month period, on HbA1c in adults with type 2 diabetes treated with a basal insulin regimen.

Status (registry)
Completed
Study type
Interventional
Enrollment
90 (actual)
First submitted
13 Feb 2024
Start date
Jul 2024
Primary completion date
Sept 2025
Lead sponsor
Abbott Diabetes Care
NCT number
NCT06268808

What you commit to

  • Study type: Interventional
  • Participants enrolled: 90
  • From Jul 2024 to the primary completion date, Sept 2025
  • 8 sites in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Currently receiving dialysis treatment or receives dialysis during the study.

Lab values

  • Currently participating in another study that could affect glucose measurements or glucose management.

Other

  • Participant is currently prescribed prandial or pre-mixed (biphasic) insulin at enrolment.
  • A female participant who is pregnant.
  • A breastfeeding female participant.

Who the study is looking for

  • Aged ≥18 to ≤ 75 years.
  • Type 2 diabetes diagnosis ≥1 year prior to enrolment.
  • Type 2 diabetes treated with a basal insulin injection regimen with or without other antihyperglycaemic therapy at enrolment.
  • Current glucose lowering treatment regimen has been established for at least 3 months prior to enrolment.
  • Screening HbA1c ≥59 mmol/mol to ≤108 mmol/mol (≥7.5% and ≤12.0%, inclusive), within the last 60 days.

Age in the registry: 18 years to 75 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (8)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Azienda Ospedaliero Universitaria Consorziale Policlinico Di Bari
Coordinator of this site? Confirm its status
BariItalyUnknown status
ASL Toscana Nordovest
Coordinator of this site? Confirm its status
CarraraItalyUnknown status
Università degli Studi di Catania, Ospedale Garibaldi-Nesima, U.O.C. Medicina Interna
Coordinator of this site? Confirm its status
CataniaItalyUnknown status
Università degli Studi di Catania, Ospedale Garibaldi-Nesima, U.O. Endocrinologia
Coordinator of this site? Confirm its status
CataniaItalyUnknown status
Azienda Ospedaliero- Universitaria "Renato Dulbecco" di Catanzaro
Coordinator of this site? Confirm its status
CatanzaroItalyUnknown status
ASL Toscana Nord Ovest
Coordinator of this site? Confirm its status
LivornoItalyUnknown status
Azienda Ospedaliero Universitaria di Parma
Coordinator of this site? Confirm its status
ParmaItalyUnknown status
La Sapienza Università di Roma, AOU Policlinico Umberto I
Coordinator of this site? Confirm its status
RomeItalyUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.